We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Responding to the Constant Emergence of Novel SARS-CoV-2 Mutants
Whitepaper

Responding to the Constant Emergence of Novel SARS-CoV-2 Mutants

Responding to the Constant Emergence of Novel SARS-CoV-2 Mutants
Whitepaper

Responding to the Constant Emergence of Novel SARS-CoV-2 Mutants

  • The novel coronavirus (SARS-CoV-2) that causes COVID-19 is a positive-sense single-stranded RNA virus, which frequently mutates during the replication step. Although most mutations have minimal impact on the characteristics of the virus, some may affectaffect its transmissibility, the severity of associated diseases and the efficacy of diagnostics, preventives and treatments.

    Download this whitepaper to learn more about evaluating the influence of SARS-CoV-2 variants on: 
  • Vaccine development
  • The development of antibody drugs
  • The development of diagnostic reagents
Advertisement